Condition: Meningioma · Sponsor: University Hospital, Montpellier
The goal of the clinical trial is to assess the presence of circulating tumor cells (CTCs) in the blood and/or cerebrospinal fluid (CSF) of patients with aggressive recurrent meningiomas.
This description comes directly from the study's public registry record.
Julien BOETTO, Dr · 0467337488 · j-boetto@chu-montpellier.fr
Always discuss trial participation with your own doctor first.
| CHU de Montpellier | Montpellier, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07398170